Description
UPNEEQ ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is a prescription eyedrop used to treat acquired blepharoptosis (low-lying lids) in adults.
Additional Information
Benefits
Lifts eyelid(s) quickly
Most patients in clinical trials had a lift in their eyelids in as little as 2 hours
84% of patients had some form of improvement
74% of patients had more than a 50% improvement
In one study, some patients saw a lift in their eyelids as fast as 5 minutes after the first dose
Significantly improves upper field of vision
In clinical trials, Upneeq helped patients with acquired ptosis see more—on the first day of treatment!
87.8% of patients had some form of improvement
40.8% of patients had at least a 50% improvement on Day 14 (2 hours after applying Upneeq)
Usage
Cut open foil wrapper and remove single-use vial
Step 2: Apply one drop of Upneeq in each affected eye as directed, once a day
Do not let the tip of the vial touch your eye or any other surface
Vials should not be re-used after opening and should be thrown away after applying drop(s)
If you wear contact lenses, remove them before applying Upneeq eyedrops
You may put them back in 15 minutes after applying Upneeq
If more than one topical ophthalmic drug is being used, the drugs should be administered at least 15 minutes between applications
Ingredients
n/a
UPNEEQ ® (oxymetazoline hydrochloride ophthalmic solution), 0.1%
contains oxymetazoline hydrochloride, an alpha adrenoceptor agonist. UPNEEQ ® is an aseptically prepared, sterile, nonpreserved ophthalmic solution. Each mL of UPNEEQ ® (oxymetazoline hydrochloride ophthalmic solution) 0.1% contains 1 mg of oxymetazoline hydrochloride, equivalent to 0.09 mg (0.09%) of oxymetazoline free base. The ophthalmic solution contains the following inactive ingredients: calcium chloride, hydrochloric acid (used to adjust pH to 5.8 to 6.8), hypromellose, magnesium chloride, potassium chloride, sodium acetate, sodium chloride, sodium citrate, and water for injection.
